Methylation biomarkers are important because they provide insights into the regulation of gene expression and the maintenance of cellular identity. They are particularly valuable in the context of cancer, where abnormal DNA methylation patterns can indicate the presence of tumor cells and provide information about the type and stage of the cancer. Additionally, methylation biomarkers can be used in the diagnosis and prognosis of various diseases, including cardiovascular diseases and neurological disorders.
